Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Alessandro, Piovesan"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marco Barale, Alice Nervo, Andrea Craparo, Alessia Pusterla, Francesca Retta, Federica Maiorino, Elena Castellano, Alessandro Piovesan, Laura Gianotti, Giorgio Borretta, Massimo Procopio, Emanuela Arvat
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionThere are few data regarding the clinical outcome of patients with parathyroid carcinoma (PC) and atypical adenoma (AA) after surgery. Aim of our study was to investigate disease recurrence and mortality rate as well as their predictors i
Externí odkaz:
https://doaj.org/article/202ddf1da94747669570efde95f13f69
Autor:
Giulia Arrigoni, Erika Crosetti, Milena Freddi, Alessandro Piovesan, Ruth Rossetto Giaccherino, Giovanni Succo, Nicola Palestini
Publikováno v:
Acta Otorhinolaryngologica Italica, Vol 42, Iss 1, Pp 41-54 (2022)
Externí odkaz:
https://doaj.org/article/440c9250b09e44beb8fd04e4d86eacf8
Autor:
Van Hulse, Camil
Publikováno v:
Books Abroad, 1952 Apr 01. 26(2), 192-192.
Externí odkaz:
https://www.jstor.org/stable/40091071
Autor:
Virginia Liberini, Osvaldo Rampado, Elena Gallio, Bruno De Santi, Francesco Ceci, Beatrice Dionisi, Philippe Thuillier, Libero Ciuffreda, Alessandro Piovesan, Federica Fioroni, Annibale Versari, Filippo Molinari, Désirée Deandreis
Publikováno v:
Frontiers in Medicine, Vol 7 (2021)
Aim: This work aims to evaluate whether the radiomic features extracted by 68Ga-DOTATOC-PET/CT of two patients are associated with the response to peptide receptor radionuclide therapy (PRRT) in patients affected by neuroendocrine tumor (NET).Methods
Externí odkaz:
https://doaj.org/article/fdfaa2f732674b60aef12cba04b33a05
Autor:
Francesco Quaglino, Luca Manfrino, Luca Cestino, Massimo Giusti, Enrico Mazza, Alessandro Piovesan, Nicola Palestini, Corrado Lauro, Elena Castellano
Publikováno v:
International Journal of Endocrinology, Vol 2020 (2020)
Parathyroid carcinoma (PC) is a rare disease responsible for about 1% of primary hyperparathyroidism (PHPT) cases. PC usually has an indolent course, tough to differentiate from the benign causes of PHPT, and the only certain diagnosis is histologic.
Externí odkaz:
https://doaj.org/article/266ae4f9b340472180b25e625cd47460
Autor:
Alice Nervo, Matteo Ferrari, Giovanni Gruosso, Enrica Migliore, Sara Basile, Valentina D’Angelo, Anna Roux, Alessandro Piovesan, Emanuela Arvat
Publikováno v:
Clinical and Experimental Medicine.
Autor:
Virginia Liberini, Martin W. Huellner, Serena Grimaldi, Monica Finessi, Philippe Thuillier, Alfredo Muni, Riccardo E. Pellerito, Mauro G. Papotti, Alessandro Piovesan, Emanuela Arvat, Désirée Deandreis
Publikováno v:
Diagnostics, Vol 10, Iss 12, p 1083 (2020)
The NETTER-1 study has proven peptide receptor radionuclide therapy (PRRT) to be one of the most effective therapeutic options for metastatic neuroendocrine tumors (NETs), improving progression-free survival and overall survival. However, PRRT respon
Externí odkaz:
https://doaj.org/article/d18426241e8b43d99e21184b656ee7ff
Autor:
Giorgio Grani, Michele Gentili, Federico Siciliano, Domenico Albano, Valentina Zilioli, Silvia Morelli, Efisio Puxeddu, Maria Chiara Zatelli, Irene Gagliardi, Alessandro Piovesan, Alice Nervo, Umberto Crocetti, Michela Massa, Maria Teresa Samà, Chiara Mele, Maurilio Deandrea, Laura Fugazzola, Barbara Puligheddu, Alessandro Antonelli, Ruth Rossetto, Annamaria D’Amore, Graziano Ceresini, Roberto Castello, Erica Solaroli, Marco Centanni, Salvatore Monti, Flavia Magri, Rocco Bruno, Clotilde Sparano, Luciano Pezzullo, Anna Crescenzi, Caterina Mian, Dario Tumino, Andrea Repaci, Maria Grazia Castagna, Vincenzo Triggiani, Tommaso Porcelli, Domenico Meringolo, Laura Locati, Giovanna Spiazzi, Giulia Di Dalmazi, Aris Anagnostopoulos, Stefano Leonardi, Sebastiano Filetti, Cosimo Durante
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
ContextThe risk stratification of patients with differentiated thyroid cancer (DTC) is crucial in clinical decision making. The most widely accepted method to assess risk of recurrent/persistent disease is described in the 2015 American Thyroid Assoc
Autor:
Osvaldo Rampado, Emanuela Arvat, Ronan Abgral, Philippe Thuillier, Désirée Deandreis, Serena Grimaldi, Alessandro Piovesan, Roberto Filippi, Filippo Molinari, E. Gallio, Bruno De Santi, Virginia Liberini
Publikováno v:
Journal of Nuclear Medicine. 63:1014-1020
Aim: To evaluate the prognostic value of somatostatin receptor tumor burden (SRTB) at 68Ga-DOTATOC positron emission tomography/computed tomography (PET/CT) in patients with well-differentiated neuroendocrine tumors (WD-NETs). Methods: We retrospecti